Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Pioglitazone for HIV-Associated Metabolic Abnormalities
NCT01612858Phase 4Completed
- Sponsor
- Tufts Medical Center
- Start
- Jun 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs), pioglitazone in HIV-associated lipodystrophy (HALS), insulin resistance (IR), sponsored by Tufts Medical Center. Started Jun 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)pioglitazone
03
Conditions
HIV-associated lipodystrophy (HALS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT01612858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612858.